Some cancers respond well to immunotherapy, a medication therapy that prompts the immune system to target tumours, although results against lung cancer have been conflicting.
When HIV patients get antiviral medication (ART), their viral levels are reduced to the point that a conventional blood test cannot detect the virus. However, once ART is discontinued, detectable HIV resurfaces, infecting new cells. The cells that release the virus to re-ignite the infection
A new study by researchers at The Ohio State University Comprehensive Cancer Center -- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC -- James) suggests a way to re-energize critical killer immune cells that have become exhausted when fighting cancer or chro
"It's easy to deliver and doesn't need any syringe or needle and most important it produces three immune responses, IgG, IgA, & T cell response. No other vaccine in the world can produce three responses," said Dr Krishna Ella, Chairman & MD, Bharat Biotech on the launch of the 'iNCOV
A mechanism has been identified by researchers from the University of Michigan Rogel Cancer Center that explains why some patients' cancers grow in response to immunotherapy rather than shrinking.
For a long time, researchers have worked to understand the immune reactions that take place in the human body during various illnesses, such as cancer and inflammatory disorders.
Nano-sized membrane bubbles known as extracellular vesicles activate the immune system in mice and seem to render their tumours sensitive to a type of immunotherapy drug called a checkpoint inhibitor. This is according to a new study published in Cancer Immunology Research by researchers at
A syndrome known as immunological "exhaustion" occurs when the immune system, particularly T cells, are severely weakened by cancer and severe viral infections. Overcoming immunological exhaustion is a key goal in the development of new drugs for serious viral infections or cancer.
Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid suppressor cells.
The human immune system is a very intricate network of cells, signals, and reactions that is strictly regulated in order to ensure that the body can fight off infection without injuring its own tissues
An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine. The finding suggests that the enzyme may be a potential target for f